Tfg Asset Management Gp LTD Celldex Therapeutics, Inc. Transaction History
Tfg Asset Management Gp LTD
- $453 Million
- Q3 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 303,600 shares of CLDX stock, worth $7.76 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
303,600
Previous 316,150
3.97%
Holding current value
$7.76 Million
Previous $6.43 Million
22.09%
% of portfolio
1.74%
Previous 1.63%
Shares
4 transactions
Others Institutions Holding CLDX
# of Institutions
205Shares Held
66.8MCall Options Held
222KPut Options Held
234K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$148 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$101 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...